相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Otolaryngology-Specific Symptoms May Be Highly Observed in Patients With a History of Covid-19 Infection After Inactivated Coronavirus Vaccination
Hakan Avci et al.
ENT-EAR NOSE & THROAT JOURNAL (2023)
Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021
Andrea Ossato et al.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2023)
COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection
Marcin Straburzynski et al.
CEPHALALGIA (2022)
Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19
Karl Messlinger et al.
CEPHALALGIA (2022)
The characteristics of COVID-19 vaccine-related headache: Clues gathered from the healthcare personnel in the pandemic
Esme Ekizoglu et al.
CEPHALALGIA (2022)
Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study
Koji Sekiguchi et al.
CEPHALALGIA (2022)
The effect of a single dose of BNT162b2 vaccine on the incidence of severe COVID-19 infection in patients on chronic hemodialysis: a single-centre study
Gabor Cserep et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2022)
Survey data of COVID-19 vaccine side effects among hospital staffin a national referral hospital in Indonesia
Dovy Djanas et al.
DATA IN BRIEF (2021)
Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan
Takehiro Izumo et al.
RESPIRATORY INVESTIGATION (2021)
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Shengli Xia et al.
LANCET INFECTIOUS DISEASES (2021)
Multiple Neuroinvasive Pathways in COVID-19
Dmitri Bougakov et al.
MOLECULAR NEUROBIOLOGY (2021)
COVID-19 vaccination among Spanish nephrologists: Acceptance and side effects
B. Quiroga et al.
JOURNAL OF HEALTHCARE QUALITY RESEARCH (2021)
Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research
Edoardo Caronna et al.
CURRENT PAIN AND HEADACHE REPORTS (2021)
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)
Biyan Nathanael Harapan et al.
JOURNAL OF NEUROLOGY (2021)
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
Sara Y. Tartof et al.
LANCET (2021)
Virtual Issue: COVID-19 and headache
Sarah M. Bobker et al.
HEADACHE (2021)
A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache
Armando Perrotta et al.
PANMINERVA MEDICA (2021)
Description of symptom course in a telemedicine monitoring clinic for acute symptomatic COVID-19: a retrospective cohort study
James B. O'Keefe et al.
BMJ OPEN (2021)
COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome
Massimo Franchini et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China
Mei-Xian Zhang et al.
EXPERT REVIEW OF VACCINES (2021)
Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers
Renuka A. K. Kadali et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response
Yael Peled et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
Fulvia Pimpinelli et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study
Jitao Wang et al.
JOURNAL OF HEPATOLOGY (2021)
Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms
Renuka Ananth Kalyan Kadali et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Shilong Yang et al.
LANCET INFECTIOUS DISEASES (2021)
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2 dose-ranging study ,
Paul A. Goepfert et al.
LANCET INFECTIOUS DISEASES (2021)
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J. Chappell et al.
LANCET INFECTIOUS DISEASES (2021)
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Cristina Menni et al.
LANCET INFECTIOUS DISEASES (2021)
COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
Anat Achiron et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
Brian J. Ward et al.
NATURE MEDICINE (2021)
Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls
Benedikt Simon et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
Tom T. Shimabukuro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
V. Shinde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Safety survey by clinical pharmacists on COVID-19 vaccination from a single center in China
Guangfei Wang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic
Abanoub Riad et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database
Mansour Tobaiqy et al.
VACCINES (2021)
The Incidence and Severity of Post-Vaccination Reactions after Vaccination against COVID-19
Izabela Jeskowiak et al.
VACCINES (2021)
Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium
Sherry H. -Y. Chou et al.
JAMA NETWORK OPEN (2021)
Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study
Nagla A. El-Shitany et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV
Jake A. Ruddy et al.
AIDS (2021)
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
Victoria Furer et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Maternal and Child Symptoms Following COVID-19 Vaccination Among Breastfeeding Mothers
Skyler McLaurin-Jiang et al.
BREASTFEEDING MEDICINE (2021)
Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase II trial
Ya-Jun Shu et al.
CHINESE MEDICAL JOURNAL (2021)
Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study
Miguel Garcia-Grimshaw et al.
CLINICAL IMMUNOLOGY (2021)
COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center
Randi von Wrede et al.
EPILEPSY & BEHAVIOR (2021)
Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel
Itay Lotan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England
Annabel A. Powell et al.
EUROSURVEILLANCE (2021)
Adverse reactions to Pfizer-BioNTech vaccination of healthcare workers at Malta's state hospital
Sarah Cuschieri et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
Myocarditis and Pericarditis After Vaccination for COVID-19
George A. Diaz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial
Nawal Al Kaabi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis
David Garcia-Azorin et al.
JOURNAL OF HEADACHE AND PAIN (2021)
Safety of COVID-19 vaccines
Qutaiba A. Al Khames Aga et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Side Effects after Second Dose of Covishield Vaccine among Healthcare Workers: A Descriptive Cross-sectional Study
Khilasa Pokharel et al.
JOURNAL OF NEPAL MEDICAL ASSOCIATION (2021)
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
Alberto M. Borobia et al.
LANCET (2021)
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
Mine Durusu Tanriover et al.
LANCET (2021)
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial
Bihua Han et al.
LANCET INFECTIOUS DISEASES (2021)
A comprehensive analysis of the efficacy and safety of COVID-19 vaccines
Changjing Cai et al.
MOLECULAR THERAPY (2021)
Underdiagnosis and undertreatment of migraine in Poland
Olga P. Fermo
NEUROLOGIA I NEUROCHIRURGIA POLSKA (2021)
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
Robert W. Frenck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
Paul T. Heath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Vaccine-Induced Thrombocytopenia with Severe Headache
Farid Salih et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
ChAdOx1 COVID-19 vaccine-induced thrombocytopenia syndrome
Y-H Wang et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2021)
Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey
Somy Cherian et al.
RHEUMATOLOGY INTERNATIONAL (2021)
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study
Elena Campello et al.
THROMBOSIS RESEARCH (2021)
Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept
Michael T. Ou et al.
TRANSPLANTATION (2021)
Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine
S. Bookstein Peretz et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2021)
Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease: A case control study
Aurelie Baldolli et al.
VACCINE (2021)
Covid-19: Regulators warn that rare Guillain-Barre cases may link to J&J and AstraZeneca vaccines
Owen Dyer
BMJ-BRITISH MEDICAL JOURNAL (2021)
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
Cristina Bergamaschi et al.
CELL REPORTS (2021)
Subjective Feelings of Polish Doctors after Receiving the COVID-19 Vaccine
Krzysztof Zdziarski et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Can reactogenicity predict immunogenicity after COVID-19 vaccination?
Young Hoon Hwang et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2021)
Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021
Heather M. Scobie et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey
Abanoub Riad et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Pfizer-BioNTech COVID-19 Vaccine Tolerance in Allergic versus Non-Allergic Individuals
Marita Nittner-Marszalska et al.
VACCINES (2021)
Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines
Osama Abu-Hammad et al.
VACCINES (2021)
Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection
Jose Javier Morales-Nunez et al.
VACCINES (2021)
Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia
Abdulaziz Alhazmi et al.
VACCINES (2021)
Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects
Ma'mon M. Hatmal et al.
VACCINES (2021)
Impacts of Side Effects to BNT162b2 and the First Dose of ChAdOx1 Anti-SARS-CoV-2 Vaccination on Work Productivity, the Need for Medical Attention, and Vaccine Acceptance: A Multicenter Survey on Healthcare Workers in Referral Teaching Hospitals in the Republic of Korea
Tark Kim et al.
VACCINES (2021)
Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study
Carl H. Goebel et al.
PAIN AND THERAPY (2021)
Allergic Reactions After COVID-19 Vaccination-Putting Risk Into Perspective
Elizabeth J. Phillips
JAMA NETWORK OPEN (2021)
Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study
Carl H. Goebel et al.
BRAIN COMMUNICATIONS (2021)
Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers
Joon Young Song et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
Bilateral Thalamic Stroke: A Case of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) or a Coincidence Due to Underlying Risk Factors?
Richard Giovane et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
2019 Novel Coronavirus Vaccination among Post-graduate Residents and Fellows
Mostafa Abohelwa et al.
JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH (2021)
Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial
Yuyi Liao et al.
EMERGING MICROBES & INFECTIONS (2021)
Emergency Department Utilization by In-hospital Healthcare Workers after COVID-19 Vaccination
Min Ji Park et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
Association between previous infection with SARS CoV-2 and the risk of self-reported symptoms after mRNA BNT162b2 vaccination: Data from 3,078 health care workers
Antonella d'Arminio Monforte et al.
ECLINICALMEDICINE (2021)
Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials
Fan-Yue Meng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial
Wanshen Guo et al.
ECLINICALMEDICINE (2021)
Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea
Yun Woo Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials
Hong-Xing Pan et al.
CHINESE MEDICAL JOURNAL (2021)
Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System
Minji Jeon et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience
Si Ho Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea
Seongman Bae et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
Pablo Tebas et al.
ECLINICALMEDICINE (2021)
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms
Abdul Mannan Baig et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Nervous system damage after COVID-19 infection: Presence or absence?
Yeshun Wu et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
Claudio Liguori et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Headache medication and the COVID-19 pandemic
Antoinette MaassenVanDenBrink et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019
Jerome R. Lechien et al.
JOURNAL OF INTERNAL MEDICINE (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis
Israel Junior Borges do Nascimento et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials
Shengli Xia et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y. Logunov et al.
LANCET (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019
T. J. Steiner et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
Catherine Collignon et al.
FRONTIERS IN IMMUNOLOGY (2020)
Coronavirus vaccine development: from SARS and MERS to COVID-19
Yen-Der Li et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Phenotypic characterization of acute headache attributed to SARS-CoV-2: An ICHD-3 validation study on 106 hospitalized patients
Javier Trigo Lopez et al.
CEPHALALGIA (2020)
Headache yesterday in Karnataka state, India: prevalence, impact and cost
Timothy J. Steiner et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Rayyan-a web and mobile app for systematic reviews
Mourad Ouzzani et al.
SYSTEMATIC REVIEWS (2016)
Headache yesterday in Russia: its prevalence and impact, and their application in estimating the national burden attributable to headache disorders
Ilya Ayzenberg et al.
JOURNAL OF HEADACHE AND PAIN (2015)
Lifetime prevalence and underdiagnosis of migraine in a population sample of Mexican women
C. Arroyo-Quiroz et al.
CEPHALALGIA (2014)
Headache yesterday in Europe
Colette Andree et al.
JOURNAL OF HEADACHE AND PAIN (2014)
Headache yesterday in China: A new approach to estimating the burden of headache, applied in a general-population survey in China
Shengyuan Yu et al.
CEPHALALGIA (2013)
Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults
Stephanie Pepin et al.
VACCINE (2013)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)